Platelet reactivity in response to loading dose of atorvastatin or rosuvastatin in patients with stable coronary disease before percutaneous coronary intervention: The STATIPLAT randomized study.
Cosmo GodinoAnne Giulia PavonAntonio MangieriAnna SalernoMichela CeraAlberto MonelloAlaide ChieffoValeria MagniAlberto CappellettiAlberto MargonatoAntonio ColomboPublished in: Clinical cardiology (2017)
Loading dose of atorvastatin (80 mg) or rosuvastatin (40 mg) did not induce significant variation in platelet reactivity in CSA patients with baseline reduced platelet reactivity as in chronic DAPT. Our data confirm that chronic concomitant treatment with low-dose statins and clopidogrel resulted in significantly lower platelet reactivity compared with clopidogrel alone.
Keyphrases
- percutaneous coronary intervention
- antiplatelet therapy
- acute coronary syndrome
- low dose
- coronary artery disease
- st segment elevation myocardial infarction
- acute myocardial infarction
- st elevation myocardial infarction
- coronary artery bypass grafting
- heart failure
- high dose
- type diabetes
- electronic health record